)
Seah Lim
Chief Executive Officer,
Medicovestor Inc
Seah, CEO of Medicovestor, Inc., boasts 25+ years of leadership in academia and biotech. His roles include Product Development Consultant for major players like Bausch Health and Genzyme, and Pediatric Lead at Sanofi. Additionally, he serves as Independent Director for Emmaus Medicals, Inc., and Advisor for Genie Therapeutics, Inc. As a former oncologist, Seah offers not just scientific and industry expertise but also clinical insights. Graduating with distinction from Aberdeen University, he pursued MD and PhD training in the UK, contributing significantly to antibody engineering. He holds 11 patents, published 180+ manuscripts, and secured over $18M in research grants, notably from the National Cancer Institute. He is an Adjunct Professor at SUNY Upstate Medical University and the Section Editor of Journal of Translational Medicine.